US Stock MarketDetailed Quotes
CJJD China Jo-Jo Drugstores
- 2.1001
- -0.0249-1.17%
Close Nov 15 16:00 ET
- 2.1001
- 0.00000.00%
Post 20:01 ET
13.97MMarket Cap-716P/E (TTM)
2.1002High2.1000Low5.67KVolume2.1000Open2.1250Pre Close11.91KTurnover0.16%Turnover RatioLossP/E (Static)6.65MShares5.000052wk High0.89P/B7.62MFloat Cap1.340052wk Low--Dividend TTM3.63MShs Float2640.0000Historical High--Div YieldTTM0.01%Amplitude1.3400Historical Low2.0990Avg Price1Lot Size
China Jo-Jo Drugstores Key Stats
Quarterly+Annual
YOY
| (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (Q4)Mar 31, 2021 | (Q3)Dec 31, 2020 | (Q2)Sep 30, 2020 | (Q1)Jun 30, 2020 | (FY)Mar 31, 2020 | (Q4)Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.85%154.54M | -9.48%148.81M | 23.48%164.39M | 13.47%133.13M | 17.70%35.7M | 6.52%35.54M | 8.78%30.84M | 22.84%31.05M | 9.09%117.33M | 14.66%30.33M |
| Operating revenue | 3.85%154.54M | -9.48%148.81M | 23.48%164.39M | 13.47%133.13M | 17.70%35.7M | 6.52%35.54M | 8.78%30.84M | 22.84%31.05M | 9.09%117.33M | 14.66%30.33M |
| Cost of revenue | 7.77%123.43M | -10.43%114.53M | 23.08%127.87M | 13.17%103.89M | 18.90%29.54M | 5.26%27.45M | 10.02%23.83M | 20.06%23.07M | 11.35%91.8M | 24.87%24.84M |
| Gross profit | -9.25%31.11M | -6.13%34.28M | 24.88%36.52M | 14.56%29.24M | 12.31%6.16M | 11.04%8.09M | 4.77%7.01M | 31.66%7.98M | 1.67%25.53M | -16.32%5.49M |
| Operating expense | -37.25%34.64M | 41.32%55.21M | 3.20%39.06M | 18.65%37.85M | -19.57%6.47M | 114.77%14.45M | 2.74%8.54M | -4.85%8.39M | 22.77%31.9M | 159.22%8.04M |
| Selling and administrative expenses | -37.25%34.64M | 41.32%55.21M | 3.20%39.06M | 18.65%37.85M | -19.57%6.47M | 114.77%14.45M | 2.74%8.54M | -4.85%8.39M | 22.77%31.9M | 159.22%8.04M |
| -Selling and marketing expense | -6.14%27.39M | -5.51%29.18M | 14.55%30.88M | 13.29%26.95M | 4.97%5.94M | 45.56%8.26M | -0.16%6.48M | 5.09%6.27M | -1.94%23.79M | -26.71%5.66M |
| -General and administrative expense | -72.12%7.26M | 217.92%26.03M | -24.87%8.19M | 34.40%10.9M | -77.99%523.61K | 487.47%6.19M | 13.03%2.06M | -25.65%2.12M | 371.69%8.11M | 151.45%2.38M |
| Operating profit | 83.11%-3.53M | -722.18%-20.93M | 70.44%-2.55M | -35.03%-8.61M | 88.08%-304.43K | -1,251.65%-6.37M | 5.70%-1.52M | 85.05%-412.35K | -627.69%-6.38M | -173.88%-2.55M |
| Net non-operating interest income expense | -38.51%503.03K | 485.57%818.05K | -44.71%139.7K | -30.81%252.69K | 121.36%63.2K | -69.46%83.31K | -79.45%69.98K | -24.38%36.2K | 223.54%365.23K | -1,530.24%-295.93K |
| Non-operating interest income | -41.55%516.64K | 119.92%883.91K | -43.22%401.92K | -33.45%707.88K | -59.41%163.42K | -29.17%193.21K | -44.89%187.67K | 241.71%163.59K | 842.31%1.06M | 1,845.71%402.59K |
| Non-operating interest expense | -79.34%13.6K | -74.89%65.85K | -42.39%262.22K | -34.84%455.19K | -85.65%100.21K | --109.9K | --117.69K | --127.39K | --698.52K | --698.52K |
| Other net income (expense) | -78.97%-1.14M | -307.63%-636.91K | 2,434.51%306.75K | 102.81%12.1K | 119.46%66.01K | 98.04%-7.22K | -40.49%-91.82K | -86.77%45.13K | -2.70%-431.1K | -31.36%-339.23K |
| Gain on sale of security | 30.62%-1.61M | ---2.32M | ---- | -84.02%64.09K | --0 | 155.71%36.31K | 375.95%32.67K | -101.21%-4.89K | 222.88%401.16K | 136.66%55.91K |
| Special income (charges) | --0 | --0 | 34.88%-148.8K | 63.62%-228.51K | ---- | ---- | ---- | ---- | ---628.19K | ---- |
| -Less:Impairment of capital assets | --0 | --0 | -34.88%148.8K | -63.62%228.51K | ---- | ---- | ---- | ---- | --628.19K | ---- |
| Other non- operating income (expenses) | -72.16%467.69K | 268.81%1.68M | 158.07%455.55K | 186.50%176.52K | 26.37%294.52K | 85.61%-43.53K | -72.37%-124.5K | 180.05%50.02K | -118.69%-204.06K | 320.39%233.05K |
| Income before tax | 79.89%-4.17M | -888.46%-20.74M | 74.85%-2.1M | -29.54%-8.34M | 94.50%-175.21K | -1,473.38%-6.29M | -15.28%-1.55M | 86.03%-331.02K | -444.50%-6.44M | -199.06%-3.19M |
| Income tax | -84.07%62.86K | -64.12%394.54K | 3,375.97%1.1M | 94.60%31.64K | -55,731.25%-8.93K | -9.52%1.98K | -432.78%-18.98K | 586.34%57.57K | -87.94%16.26K | -100.05%-16 |
| Net income | 79.97%-4.23M | -560.92%-21.14M | 61.81%-3.2M | -29.70%-8.38M | 94.79%-166.28K | -1,480.40%-6.29M | -13.38%-1.53M | 83.66%-388.59K | -390.05%-6.46M | -200.00%-3.19M |
| Net income continuous Operations | 79.97%-4.23M | -560.92%-21.14M | 61.81%-3.2M | -29.70%-8.38M | 94.79%-166.28K | -1,480.40%-6.29M | -13.38%-1.53M | 83.66%-388.59K | -390.05%-6.46M | -200.00%-3.19M |
| Minority interest income | 94.44%-14 | 95.97%-252 | 97.56%-6.25K | 60.31%-255.72K | 86.24%-27.96K | 50.96%-37.2K | 72.56%-33.47K | 35.41%-157.08K | -64.58%-644.31K | -199.96%-203.22K |
| Net income attributable to the parent company | 79.97%-4.23M | -562.21%-21.14M | 60.69%-3.19M | -39.68%-8.12M | 95.37%-138.32K | -1,276.48%-6.26M | -21.94%-1.49M | 89.16%-231.51K | -527.61%-5.81M | -200.00%-2.99M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 79.97%-4.23M | -562.21%-21.14M | 60.69%-3.19M | -39.68%-8.12M | 95.37%-138.32K | -1,276.48%-6.26M | -21.94%-1.49M | 89.16%-231.51K | -527.61%-5.81M | -200.00%-2.99M |
| Basic earnings per share | 92.93%-2.93 | -125.94%-41.46 | 61.61%-18.35 | -10.69%-47.8 | 100.93%0.2002 | -850.00%-36.0001 | 0.00%-9.6 | 85.71%-2.4 | -499.76%-43.1829 | -181.75%-21.5828 |
| Diluted earnings per share | 92.93%-2.93 | -125.94%-41.46 | 61.61%-18.35 | -10.69%-47.8 | 100.93%0.2002 | -850.00%-36.0001 | 0.00%-9.6 | 85.71%-2.4 | -499.76%-43.1829 | -181.75%-21.5828 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data